glp-1 drugs and surgery Metabolic surgery and GLP-1 agonists | Blog

I-M-150847, a novel GLP-1 and GIP receptor dual agonist, reduces body weight gain and improves glycemic control in the rodent model of type 2 diabetes and obesity | bioRxiv

The US Food and Drug Administration approved #EliLilly's #Foundayo (#orforglipron) on April 1, 2026, a once-daily oral #GLP1 pill for #WeightLoss, intensifying the competition between #Lilly and Danish drug maker #NovoNordisk that

A venomous desert lizard helped inspire some of today's most powerful diabetes and weight-loss medicines. The story begins with the Gila monster, a venomous lizard from the deserts of the southwestern United

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita Procedure | Fractyl Health, Inc.

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial - The Lancet

Not all GLP medications work the same. Fat loss isn't about shortcuts. It's about using the right tools paired with training, nutrition, and accountability. Education first. Performance always. Take advantage of 50%